Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Meffre

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Biochemical and Biophysical Research Communications|May 17, 2024
Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formationChristopher K May, Philip W Noble, Erica L Herzog, et al.
The Journal of Clinical Investigation|May 25, 2012
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapyAisha V Sauer, Henner Morbach, Immacolata Brigida, et al.
Science (New York, N.Y.)|August 16, 2003
Predominant autoantibody production by early human B cell precursorsHedda Wardemann, Sergey Yurasov, Anne Schaefer, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2019
A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomasHeather Minto, Kofi A Mensah, Paul R Reynolds, et al.
The Journal of Experimental Medicine|March 2, 2005
Defective B cell tolerance checkpoints in systemic lupus erythematosusSergey Yurasov, Hedda Wardemann, Johanna Hammersen, et al.
Molecular and Cellular Biology|December 16, 2003
Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylationYuhong Shen, Karni Schlessinger, Xuejun Zhu, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The Journal of Clinical Investigation|May 20, 2005
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivityMaxime Hervé, Kai Xu, Yen-Shing Ng, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2015
CD19 controls Toll-like receptor 9 responses in human B cellsHenner Morbach, Jean-Nicolas Schickel, Charlotte Cunningham-Rundles, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2013
Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survivalNeil Romberg, Henner Morbach, Monica G Lawrence, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|May 17, 2024
Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formationChristopher K May, Philip W Noble, Erica L Herzog, et al.
The Journal of Clinical Investigation|May 25, 2012
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapyAisha V Sauer, Henner Morbach, Immacolata Brigida, et al.
Science (New York, N.Y.)|August 16, 2003
Predominant autoantibody production by early human B cell precursorsHedda Wardemann, Sergey Yurasov, Anne Schaefer, et al.
Clinical Immunology (Orlando, Fla.)|January 15, 2019
A novel ATM mutation associated with elevated atypical lymphocyte populations, hyper-IgM, and cutaneous granulomasHeather Minto, Kofi A Mensah, Paul R Reynolds, et al.
The Journal of Experimental Medicine|March 2, 2005
Defective B cell tolerance checkpoints in systemic lupus erythematosusSergey Yurasov, Hedda Wardemann, Johanna Hammersen, et al.
Molecular and Cellular Biology|December 16, 2003
Essential role of STAT3 in postnatal survival and growth revealed by mice lacking STAT3 serine 727 phosphorylationYuhong Shen, Karni Schlessinger, Xuejun Zhu, et al.
The Journal of Experimental Medicine|June 15, 2007
CD40 ligand and MHC class II expression are essential for human peripheral B cell toleranceMaxime Hervé, Isabelle Isnardi, Yen-shing Ng, et al.
The Journal of Clinical Investigation|May 20, 2005
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivityMaxime Hervé, Kai Xu, Yen-Shing Ng, et al.
The Journal of Allergy and Clinical Immunology|October 20, 2015
CD19 controls Toll-like receptor 9 responses in human B cellsHenner Morbach, Jean-Nicolas Schickel, Charlotte Cunningham-Rundles, et al.
The Journal of Allergy and Clinical Immunology|February 14, 2013
Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survivalNeil Romberg, Henner Morbach, Monica G Lawrence, et al.
Pageof 12